Evidence map›Paper›PMID 28132544›Full record

ArticleAIDS care2017

Growing challenges for HIV programmes in Asia: clinic population trends, 2003-2013.

Nicole L De La Mata, Nagalingeswaran Kumarasamy, Penh Sun Ly, Oon Tek Ng, Kinh Van Nguyen, Tuti Parwati Merati, Man Po Lee, Cuong Duy Do, Jun Yong Choi, Jeremy L Ross and 1 more

Abstract read
In one paragraph

Article in AIDS care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nicole L De La Mataa The Kirby Institute , UNSW Australia , Sydney , Australia.ORCID 0000-0001-7739-3656
Nagalingeswaran Kumarasamyb YRGCARE Medical Centre , VHS , Chennai , India.
Penh Sun Lyc National Center for HIV/AIDS , Dermatology & STDs , Phnom Penh , Cambodia.
Oon Tek Ngd Tan Tock Seng Hospital , Singapore.
Kinh Van Nguyene National Hospital for Tropical Diseases , Hanoi , Vietnam.
Tuti Parwati Meratif Faculty of Medicine , Udayana University & Sanglah Hospital , Bali , Indonesia.
Man Po Leeg Queen Elizabeth Hospital , Hong Kong SAR , China.
Cuong Duy Doh Bach Mai Hospital , Hanoi , Vietnam.
Jun Yong Choii Department of Internal Medicine and AIDS Research Institute , Yonsei University College of Medicine, Severance Hospital , Seoul , South Korea.
Jeremy L Rossj TREAT Asia, amfAR - The Foundation for AIDS Research , Bangkok , Thailand.
Matthew G Lawa The Kirby Institute , UNSW Australia , Sydney , Australia.

Funding

The Asia-Pacific HIV Research CollaborationU01AI069907 · NIAID · FOUNDATION FOR AIDS RESEARCH · PI ANNETTE H SOHN · 2006 to 2026
$44.8M
NIAID NIH HHS U01 AI069907
6 · The paper itself

Abstract

The scale-up of antiretroviral therapy (ART) has led to a substantial change in the clinical population of HIV-positive patients receiving care. We describe the temporal trends in the demographic and clinical characteristics of HIV-positive patients initiating ART in 2003-13 within an Asian regional cohort. All HIV-positive adult patients that initiated ART between 2003 and 2013 were included. We summarized ART regimen use, age, CD4 cell count, HIV viral load, and HIV-related laboratory monitoring rates during follow-up by calendar year. A total of 16 962 patients were included in the analysis. Patients in active follow-up increased from 695 patients at four sites in 2003 to 11,137 patients at eight sites in 2013. The proportion of patients receiving their second or third ART regimen increased over time (5% in 2003 to 29% in 2013) along with patients aged ≥50 years (8% in 2003 to 18% in 2013). Concurrently, CD4 monitoring has remained stable in recent years, whereas HIV viral load monitoring, although varied among the sites, is increasing. There have been substantial changes in the clinical and demographic characteristics of HIV-positive patients receiving ART in Asia. HIV programmes will need to anticipate the clinical care needs for their aging populations, expanded viral load monitoring, and, the eventual increase in second and third ART regimens that will lead to higher costs and more complex drug procurement needs.

Indexed as

Antiretroviral Therapy, Highly ActiveAdultAnti-HIV AgentsAsiaCD4 Lymphocyte CountCohort StudiesFemaleHIV InfectionsHumansMaleMiddle AgedOutcome and Process Assessment, Health CareProgram EvaluationViral LoadYoung AdultAnti-HIV AgentsARTAsiacharacteristicsclinicaldemographicsHIV

Identifiers

PMID28132544
PMCPMC5534184

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.